The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ESPERION THERAPEUTICS INC NE COMMON 29664W105 14,485 289,000 SH   DFND 1 0 0 289,000
ESPERION THERAPEUTICS INC NE COMMON 29664W105 5 100 SH   DFND   0 0 100
MACROGENICS INC. COMMON 556099109 2,142 115,914 SH   DFND 1 0 0 115,914
MEDICINES CO COMMON 584688105 113,183 3,055,689 SH   DFND 1 0 0 3,055,689
MEDICINES CO COMMON 584688105 28,825 778,210 SH   DFND   0 0 778,210
MEDICINES CO COMMON 584688105 4 100 SH   DFND   0 0 100
MIRATI THERAPEUTICS INC COMMON 60468T105 33,704 2,880,702 SH   DFND 1 0 0 2,880,702